Gene Therapy: A New Approach in Modern Medicine

سال انتشار: 1397
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 434

فایل این مقاله در 12 صفحه با فرمت PDF قابل دریافت می باشد

این مقاله در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJMR-5-3_004

تاریخ نمایه سازی: 29 خرداد 1398

چکیده مقاله:

In general, gene therapy is the transfer of a genetic material to treat a disease, or at least to improve the clinical status of a patient. One way gene therapy works is to turn viruses into genetic vectors that carry the gene of interest to the target cells. Based on the genome’s nature, these vectors are divided into RNA-based or DNA-based viral vectors. Most RNA-based vectors are derived from simple retroviruses, such as the murine leukemia virus. One major drawback of these viruses is that they are not transferred to non-dividing cells (post-mitotic cells). This problem can be solved by using new retroviral vectors derived from lentiviruses, such as the human immunodeficiency virus (HIV). DNA-based vectors originate from adeno-viruses and adeno-associated viruses (AAVs). An example of gene deletion due to gene therapy is the deletion of the human CCR5 gene in T cells (which control HIV infection). Although available vector systems have the ability to transfer genes to living cells (in the human body), an ideal vector for gene delivery has not yet been found. Therefore, the current viral vectors should be used with great caution in human cases. Moreover, the development of new vectors is necessary.

نویسندگان

Azam Yazdani

Department of Biology, Faculty of Basic Science, Shahed University, Tehran, Iran

Zahra Alirezaie

Department of Biology, Faculty of Basic Science, Shahed University, Tehran, Iran

Mohammad Javad Motamedi

Green Gene Company, Tehran, Iran

Jafar Amani

Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Patil PM, Chaudhari PD, Sahu M, Duragkar NJ. Review article ...
  • Kumar SR, Markusic DM, Biswas M, High KA, Herzog RW. ...
  • Couzin-Frankel J. Breakthrough of the year 2013. Cancer immunotherapy. Science. ...
  • Wang X, Shin SC, Chiang AF, et al. Intraosseous delivery ...
  • Brown BD. A shot in the bone corrects a genetic ...
  • Yla-Herttuala S. Endgame: glybera finally recommended for approval as the ...
  • Kaufman HL, Kohlhapp FJ, Zloza A. Oncolytic viruses: a new ...
  • Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD. ...
  • Durai S, Mani M, Kandavelou K, Wu J, Porteus MH, ...
  • Friedmann T, Roblin R. Gene therapy for human genetic disease ...
  • Harwood AJ. Protocols for gene analysis. 1st ed. Totowa, New ...
  • Ramamoorth M, Narvekar A. Non viral vectors in gene therapy-an ...
  • Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, ...
  • Wrobel I, Collins D. Fusion of cationic liposomes with mammalian ...
  • Al-Dosari MS, Gao X. Nonviral gene delivery: principle, limitations, and ...
  • Dobson J. Gene therapy progress and prospects: magnetic nanoparticle-based gene ...
  • Jones CH, Chen CK, Ravikrishnan A, Rane S, Pfeifer BA. ...
  • Woods NB, Bottero V, Schmidt M, von Kalle C, Verma ...
  • Gao X, Huang L. Potentiation of cationic liposome-mediated gene delivery ...
  • Horn PA, Morris JC, Neff T, Kiem HP. Stem cell ...
  • Farhood H, Serbina N, Huang L. The role of dioleoyl ...
  • Taymans JM, Nkiliza A, Chartier-Harlin MC. Deregulation of protein translation ...
  • van der Brug MP, Singleton A, Gasser T, Lewis PA. ...
  • Fuji RN, Flagella M, Baca M, et al. Effect of ...
  • Combs B, Kneynsberg A, Kanaan NM. Gene Therapy Models of ...
  • Tuszynski MH, Yang JH, Barba D, et al. Nerve Growth ...
  • Oakland M, Sinn PL, McCray PB, Jr. Advances in cell ...
  • Cooney AL, Abou Alaiwa MH, Shah VS, et al. Lentiviral-mediated ...
  • Amer MH. Gene therapy for cancer: present status and future ...
  • Liu SX, Xia ZS, Zhong YQ. Gene therapy in pancreatic ...
  • Stoff-Khalili MA, Dall P, Curiel DT. Gene therapy for carcinoma ...
  • Husain SR, Han J, Au P, Shannon K, Puri RK. ...
  • Ginn SL, Amaya AK, Alexander IE, Edelstein M, Abedi MR. ...
  • Aiuti A, Biasco L, Scaramuzza S, et al. Lentiviral hematopoietic ...
  • Hacein-Bey Abina S, Gaspar HB, Blondeau J, et al. Outcomes ...
  • Cavazzana-Calvo M, Payen E, Negre O, et al. Transfusion independence ...
  • Cartier N, Hacein-Bey-Abina S, Bartholomae CC, et al. Hematopoietic stem ...
  • Cartier N, Hacein-Bey-Abina S, Bartholomae CC, et al. Lentiviral hematopoietic ...
  • Biffi A, Montini E, Lorioli L, et al. Lentiviral hematopoietic ...
  • Nathwani AC, Reiss UM, Tuddenham EG, et al. Long-term safety ...
  • Baxalta reports continued progress on phase 1/2 clinical trial of ...
  • Kochenderfer JN, Dudley ME, Kassim SH, et al. Chemotherapy-refractory diffuse ...
  • Brentjens RJ, Davila ML, Riviere I, et al. CD19-targeted T ...
  • Maude SL, Frey N, Shaw PA, et al. Chimeric antigen ...
  • Lee DW, Kochenderfer JN, Stetler-Stevenson M, et al. T cells ...
  • Leone P, Shera D, McPhee SW, et al. Long-term follow-up ...
  • Tardieu M, Zerah M, Husson B, et al. Intracerebral administration ...
  • Li B, Ma W, Ling C, et al. Site-Directed Mutagenesis ...
  • Ferreira V, Twisk J, Kwikkers K, et al. Immune responses ...
  • Testa F, Maguire AM, Rossi S, et al. Three-year follow-up ...
  • Simonelli F, Maguire AM, Testa F, et al. Gene therapy ...
  • Maguire AM, High KA, Auricchio A, et al. Age-dependent effects ...
  • Kaufmann KB, Buning H, Galy A, Schambach A, Grez M. ...
  • Naldini L. Gene therapy returns to centre stage. Nature. 2015;526(7573):351-360. ...
  • نمایش کامل مراجع